Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • mtdsus mtdsus Aug 23, 2012 2:51 PM Flag

    Why BUY OUT failed in May,2011?

    There was an attempt to buy Amarin in April,2011 after Marine 3 trial results were public.Sun Times reported it and Amarin conformed it in June,2011 to Bloomberg reporter. on 6/10/2011.
    It was simply PRICE. Joe wanted 30$ -bidders were offering close to 15$/share.
    During last 15 months--Amarin has gotten great results for Anchor 3 trials for 200-500mg.population.
    Their patent position has improved--protection thru 2030 looks solid.(Yes,Generics will create trouble if NCE for 5 years is NOT granted)-but patents will have to be enforced by Amarin.
    NOW--8 analysts from MKM(21.50) to Jeffries (28$) are all rating it Strong Buy or BUY.
    As happened with Warner Lambert in 1997--when Merck and Pfizer were reluctant to pay big money(as results with patients were great--but CONSUMERS WILLING to switch from ZOCOR to LIPITOR was unknown).When Pfizer achieved 18% market share for Lipitor--every one was SHOCKED.
    Warner Lambert Value tripled in 1999--when bidding took place.

    SAME COULD HAPPEN in 2012--RIGHT PRICE could keep Amarin and PFIZER apart,but ultimately--Merck or Pfizer will buy AMARIN in 2013 .

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • todhale@rocketmail.com todhale Aug 23, 2012 3:20 PM Flag

      Do you think that was a lessoned learned and they'll pony up $28-31 soon? I still cannot shake the thought that reduce-it/combo potential is a smart gamble for BP down the road and they would want to lock up amrn now. My magic 8-ball is refusing to answer me anymore when I ask about amrn!

      Sentiment: Strong Buy

 
AMRN
1.93+0.10(+5.46%)3:42 PMEDT